CohBar (CWBR) Stock Price, News & Analysis

Company Overview

CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.

Key Stats

• Today's Range: $0.41 to $0.41
• 50-Day Range: $0.41 to $0.41
• 52-Week Range: $0.00 to $1.01
• Volume: N/A
• Average Volume: 4,364 shs
• Market Capitalization: $1.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CWBR Stock Analysis - Frequently Asked Questions

How have CWBR shares performed this year?

CohBar's stock was trading at $0.45 on January 1st, 2025. Since then, CWBR shares have decreased by 8.9% and is now trading at $0.41.
View the best growth stocks for 2025 here.

How were CohBar's earnings last quarter?

CohBar, Inc. (NASDAQ:CWBR) released its quarterly earnings data on Monday, November, 15th. The company reported ($1.50) EPS for the quarter, beating the consensus estimate of ($2.70) by $1.20.

When did CohBar's stock split?

Shares of CohBar reverse split on the morning of Friday, September 23rd 2022. The 1-30 reverse split was announced on Friday, September 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of CohBar?

Shares of CWBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CohBar own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CohBar investors own include ADMA Biologics (ADMA), Meta Platforms (META), 9 Meters Biopharma (NMTR), NVIDIA (NVDA), ObsEva (OBSV), Applied Genetic Technologies (AGTC) and Allena Pharmaceuticals (ALNA).

Company Calendar

• Last Earnings: 11/15/2021
• Today: 4/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CWBR
• CIK: 1522602
• Web: www.cohbar.com
• Phone: (650) 446-7888
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.27 per share
• Price / Book: 0.08

Miscellaneous

• Outstanding Shares: 2,907,000
• Free Float: N/A
• Market Cap: $1.19 million
• Optionable: Not Optionable
• Beta: 1.39